Skip to main content

Table 1 Functional characterization of SNHG3 in various cancers

From: LncRNA SNHG3, a potential oncogene in human cancers

Cancer type

Expression

Role

Biological functions

Related genes

Refs.

Breast cancer

Up

Oncogenic

Promotes cell proliferation, migration and invasion

miR-384/HDGF

[31,32,33]

miR-330-5p/PKM

miR-326/ITGA5, Vav2/Rac1

Osteosarcoma

Up

Oncogenic

Promotes cell proliferation, migration, invasion and EMT

miR-151a-3p/RAB22A, miR-196a-5p/HOXC8

[25, 38]

Glioma

Up

Oncogenic

Promores cell proliferation, inhibits apoptosis, and regulates cell cycle

KLF2, p21, EZH2

[24]

Laryngeal cancer

UP

Oncogenic

Promotes cell migration, invasion and cell viability, glycolysis

miR-384/WEE1, MMP2, MMP9

[44, 45]

miR-340-5p/YAP1, Wnt/β-catenin

Gastric cancer

Up

Oncogenic

Promotes cell proliferation, migration, invasion and cell viability

EZH2, MED18

[23]

Colorectal cancer

Up

Oncogenic

Promotes cell proliferation, migration, invasion and cell viability

miR-182-5p/c-Myc, miR-539/RUNX2

[53, 54]

Renal cell carcinoma

Up

Oncogenic

Promotes cell proliferation, cell viability, migration, invasion and EMT and inhibits cell apoptosis

miR-139-5p/TOP2A, CDK6, Bax, Bcl-2, N-cadherin, E-cadherin, Vimentin

[57]

Hepatocellular carcinomac

Up

Oncogenic

Promotes cell proliferation, apoptosis, migration, invasion, EMT and sorafenib resistance

miR-139-5p/BMI1, miR-326/SMAD3/ZEB1, miR-128/CD151/AKT/PI3K, N-cadherin, E-cadherin, Vimentin, Snail

[60,61,62,63]

Lung cancer

Up

Oncogenic

Promotes cell proliferation, migration and EMT, inhibits cell apoptosis and regulates cell cycle

TGF-β, IL-6/JAK2/STAT3

[66, 67]

Acute myeloid leukemia

Up

Oncogenic

Promotes cell proliferation and inhibits cell apoptosis

miR-758-3p/SRGN

[70, 71]

Epithelial ovarian cancer

Up

Oncogenic

Promotes cell proliferation, invasion and glycolysis

CyclinD1, CDK1, MMP9, MMP3, GSK3β/β-catenin, EIF4A3-mRNA

[26, 74]

Papillary thyroid carcinoma

Up

Oncogenic

Promotes cell proliferation, migration and invasion

miR-214-3p/PSMD10

[76]

Down

Tumor Suppressive

Promotes cell proliferation, migration and invasion

AKT/mTOR/ERK

[77]

Prostate cancer

UP

Oncogenic

Promotes cell proliferation, migration, invasion, EMT process and inhibits cell apoptosis

miR-577/SMURF1

[78]

Bladder cancer

Up

Oncogenic

Promotes cell proliferation, migration, invasion and EMT

miR-515-5p/GINS2

[79]

Oral squamous cell carcinoma

Up

Oncogenic

Promotes cell migration, invasion and proliferation

ELAVL1/NFYC, Wnt/β-catenin

[80]

  1. EMT epithelial-mesenchymal transition, HDGF hepatoma-derived growth factor, PKM pyruvate kinase M1/M2, ITGA5 integrin α5, RAB22A Ras-related proteins 22a, HOXC8 homeobox c8, KLF2 kruppel like factor 2, p21 p21 protein, EZH2 Enhancer of zeste homolog 2, WEE1 wee1-like protein kinase, MMP2 matrix metalloproteinase-2, MMP9 matrix metalloproteinase-9, YAP1 yes-associated protein 1, MED18 mediator subunit18, RUNX2 runt-related transcription factor 2, TOP2A the expression of topoisomerase IIα, CDK6 cyclin-dependent kinase 6, N-cadherin neural-cadherin, E-cadherin epithelial-cadherin, BMI1 B lymphoma Mo-MLV insertion region 1, SMAD3 Sma and Mad Related Family 3, ZEB1 zinc finger E-box binding homeobox 1, PI3K phosphoinositide-3 kinase, TGF-β transforming growth factor-β, IL-6 the interleukin-6, JAK2 Janus kinase 2, STAT3 signal transducer and activator of transcription 3, SRGN serglycin, GSK3β glycogen synthase kinase 3 beta, EIF4A3 eukaryotic translation initiation factor 4A3, SMURF1 Smad Ubiquitin Regulatory Factor 1, GINS2 GINS complex subunit 2, PSMD10 proteasome 26S subunit non-ATPase 10, ELAVL1 ELAV like RNA-binding protein 1, NFYC nuclear transcription factor Y subunit gamma